|
Market Closed -
Nasdaq Stockholm
19:00:00 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7550 SEK | +1.21% |
|
-5.51% | +3.57% |
| 08-25 | Isofol Medical gets a new fair value estimate of 1.70 kronor from Redeye | FW |
| 08-25 | Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 239M 23.81M 21.24M 19.79M 18.01M 33.91M 2.29B 34.16M 93.02M 1.17B 89.37M 87.44M 3.76B | P/E 2026 * |
-3.93x | P/E 2027 * | -24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 239M 23.81M 21.24M 19.79M 18.01M 33.91M 2.29B 34.16M 93.02M 1.17B 89.37M 87.44M 3.76B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 7.36x |
| Free-Float |
73.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ISOFOL | Delayed | |
Deutsche Boerse AG
| 5IU | Delayed | |
|
Boerse Muenchen
| 5IU | Real-time |
| 1 day | +1.21% | ||
| 1 week | -5.51% | ||
| Current month | -0.66% | ||
| 1 month | +3.57% | ||
| 3 months | -8.82% | ||
| 6 months | +16.69% | ||
| Current year | +3.57% |
| 1 week | 0.73 |  | 0.8 |
| 1 month | 0.7 | | 0.82 |
| Current year | 0.55 | | 0.99 |
| 1 year | 0.55 | | 0.99 |
| 3 years | 0.45 | | 4.88 |
| 5 years | 0.45 | | 14.44 |
| 10 years | 0.45 | | 33.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 74 | 09/01/2024 |
Margareta Hagman
DFI | Director of Finance/CFO | 60 | 13/08/2024 |
Roger Tell
CEO | Chief Executive Officer | 61 | 22/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lars Erik Lind
CHM | Chairman | 85 | 01/07/2010 |
Alain Herrera
BRD | Director/Board Member | 76 | 01/01/2018 |
Sten Nilsson
BRD | Director/Board Member | 78 | 04/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/10/21 A | Sell | 58,767 | 0.0364% | |||
| 12/10/21 A | Sell | 58,767 | 0.0364% | |||
| 6/14/21 A | Others | Chief Financial Officer | 15,153 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.21% | -5.51% | +0.07% | -12.41% | 23.82M | |
| +0.66% | -2.93% | +36.09% | +112.39% | 1,019B | |
| -1.02% | -6.87% | +34.61% | +61.18% | 617B | |
| +0.33% | -0.91% | +14.62% | +78.94% | 464B | |
| -3.05% | -5.81% | +57.71% | +35.18% | 356B | |
| +0.93% | -1.83% | +20.98% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.09% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.56% | +7.91% | 244B | |
| -0.05% | -3.68% | +36.93% | +51.93% | 218B | |
| -0.31% | -5.36% | +26.82% | +92.83% | 179B | |
| Average | -0.29% | -3.88% | +23.04% | +50.29% | 369.72B | |
| Weighted average by Cap. | -0.29% | -3.54% | +28.71% | +68.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 32.5M 3.24M 2.89M 2.69M 2.45M 4.61M 312M 4.64M 12.64M 159M 12.15M 11.89M 511M |
| Net income | -58.5M -5.83M -5.2M -4.84M -4.41M -8.3M -561M -8.36M -22.76M -286M -21.87M -21.4M -920M | -69.3M -6.9M -6.16M -5.74M -5.22M -9.83M -665M -9.9M -26.96M -339M -25.9M -25.35M -1.09B |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | SEK 0.7550 | +1.21% | 207,468 |
| 02/10/26 | SEK 0.7460 | -0.53% | 233,509 |
| 01/10/26 | SEK 0.7500 | -1.32% | 213,041 |
| 30/09/26 | SEK 0.7600 | -2.56% | 119,434 |
| 29/09/26 | SEK 0.7800 | -2.38% | 52,386 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ISOFOL Stock
Select your edition
All financial news and data tailored to specific country editions
